OMCL 📈 Omnicell - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US68213N1090

OMCL: Automation Systems, Dispensing Systems, Robotics, Software, Packaging Supplies

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. Web URL: https://www.omnicell.com

Additional Sources for OMCL Stock

OMCL Stock Overview

Market Cap in USD 2,099m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2001-08-07

OMCL Stock Ratings

Growth 5y -41.0%
Fundamental -10.2%
Dividend -
Rel. Strength Industry 261
Analysts 3.78/5
Fair Price Momentum 40.05 USD
Fair Price DCF 66.04 USD

OMCL Dividends

No Dividends Paid

OMCL Growth Ratios

Growth Correlation 3m 50.6%
Growth Correlation 12m 65.8%
Growth Correlation 5y -65.8%
CAGR 5y -11.53%
CAGR/Mean DD 5y -0.28
Sharpe Ratio 12m 0.43
Alpha -8.37
Beta 0.86
Volatility 46.64%
Current Volume 2644.2k
Average Volume 20d 634.2k
What is the price of OMCL stocks?
As of December 22, 2024, the stock is trading at USD 44.98 with a total of 2,644,184 shares traded.
Over the past week, the price has changed by -2.24%, over one month by +7.56%, over three months by +0.81% and over the past year by +18.59%.
Is Omnicell a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Omnicell is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.24 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OMCL as of December 2024 is 40.05. This means that OMCL is currently overvalued and has a potential downside of -10.96%.
Is OMCL a buy, sell or hold?
Omnicell has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold OMCL.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecast for OMCL stock price target?
According to ValueRays Forecast Model, OMCL Omnicell will be worth about 43.4 in December 2025. The stock is currently trading at 44.98. This means that the stock has a potential downside of -3.62%.
Issuer Forecast Upside
Wallstreet Target Price 56.6 25.8%
Analysts Target Price 66.4 47.7%
ValueRay Target Price 43.4 -3.6%